Records containing: Sarcoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-11-20Non-randomized Single-center Study Phase II Evaluating the Efficacy and Toxicity of Autologous Dendritic Cell Vaccine Loaded With Allogeneic Tumor Lysate Expression of Cancer Testis Antigens in Patients With Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2019-11-08Applying PET/MR in Oncology - a Prospective Project
-
CLINICAL_TRIALS study record update · 2019-10-29A Phase II Trial of Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma
-
CLINICAL_TRIALS study record update · 2019-10-15Anti-PD-1 Antibody SHR-1210 (Camrelizumab) Combined With Apatinib Mesylate in the Treatment of Unresectable Sarcoma With Chemotherapy Failure: an Open, Non-randomized Phase II Clinical Study
-
CLINICAL_TRIALS study record update · 2019-10-01A Phase II Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor and Other Non-Carcinomas
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-10-01A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
-
CLINICAL_TRIALS study record update · 2019-09-27A Phase I Dose-escalation Trial to Evaluate Haploidentical / Allogeneic Natural Killer Group 2D Ligand (NKG2DL)-Targeting Chimeric Antigen Receptor-grafted Gamma Delta (γδ) T Cells (CTM-N2D) in Subjects With Relapsed or Refractory Solid Tumour
-
CLINICAL_TRIALS study record update · 2019-08-26Randomized Open-label Phase 1b Study of Doxorubicin-based Chemotherapy Regimens, With and Without Sildenafil, With Exploratory Analysis of Intermediate Cardiac Markers
-
CLINICAL_TRIALS study record update · 2019-08-19A Phase I Trial of CBT-1® in Combination With Doxorubicin in Patients With Locally Advanced or Metastatic, Unresectable Sarcomas Previously to Have Progressed on 150 mg/m2 or Less of Doxorubicin
-
CLINICAL_TRIALS study record update · 2019-07-16Phase I Trial and Pharmacokinetic Study of Tariquidar (XR9576), a P-Glycoprotein Inhibitor, in Combination With Doxorubicin, Vinorelbine or Docetaxel in Pediatric Patients With Refractory Solid Tumors Including Brain Tumors
-
CLINICAL_TRIALS study record update · 2019-07-01A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
-
CLINICAL_TRIALS study record update · 2019-06-27Phase II Clinical Study of Concurrent Pazopanib for Non-metastatic Sarcoma Patients to be Treated With Radiotherapy, Localized in the Extremities, Trunk and Chest Wall or the Head and Neck Region (PASART-2)
-
CLINICAL_TRIALS study record update · 2019-05-02A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
-
CLINICAL_TRIALS study record update · 2019-04-08Pilot Project to Better Understand Non-Clinical Needs of Cancer Patients
-
CLINICAL_TRIALS study record update · 2019-04-02Patients Diagnosed With Advanced Malignancy or Myelodysplasia, Tested by Standardized Sequencing, and Treated by Physician-Determined Care Plan: A CureOne Observational Registry (N1)
-
CLINICAL_TRIALS study record update · 2019-03-26Development of Quantitative Imaging Biomarkers for Evaluating Sarcoma Patients
-
CLINICAL_TRIALS study record update · 2019-03-21Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma : a One-arm, Multi-center, Prospective Clinical Trial (ALTER-S001)
-
CLINICAL_TRIALS study record update · 2019-03-20Ultra-Sensitive, Infra-Red Thermographic Analysis of Kaposi's Sarcoma Skin Lesions
-
CLINICAL_TRIALS study record update · 2019-03-19ClinicalTrials.gov study NCT02557854
-
CLINICAL_TRIALS study record update · 2019-03-11Phase I/II Trial of Torisel and Liposomal Doxorubicin in Patients With Advanced Soft Tissue and Bone Sarcomas
-
CLINICAL_TRIALS study record update · 2019-03-06Phase 2 Study of the mTOR Inhibitor Everolimus in Combination With Bevacizumab in Patients With Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors
-
CLINICAL_TRIALS study record update · 2018-11-19Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications
-
CLINICAL_TRIALS study record update · 2018-11-07A Pilot Study of Aranesp (Darbepoetin Alfa) and Pegfilgrastim (Neulasta) in Patients With Sarcoma Receiving Adriamycin and Ifosfamide
-
CLINICAL_TRIALS study record update · 2018-10-30Randomized Double-blind Placebo-controlled Trial of Primary Prophylaxis With Recombinant Human Thrombopoietin Administered to Patients With High Risk Sarcoma Receiving Intensive Chemotherapy
-
CLINICAL_TRIALS study record update · 2018-10-09A Pilot Study for Soft Tissue Sarcoma